Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing ibandronate sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ibandronate sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ibandronate sodium 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ibandronate sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ibandronate sodium 150 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ibandronate sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ibandronate sodium 1mg/mL injection solution 3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ibandronate sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ibandronate sodium 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ibandronate sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ibandronate sodium 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ibandronate sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ibandronate sodium 150 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ibandronate sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ibandronate sodium 150 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Ibandronate sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ibandronate sodium monohydrate |
Is a |
False |
Ibandronate sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ibandronate sodium 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ibandronate sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ibandronate sodium 150 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Ibandronate sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ibandronate sodium monohydrate |
Is modification of (attribute) |
True |
Ibandronate sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Ibandronate sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ibandronic acid (as ibandronate sodium) 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ibandronate sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ibandronic acid (as ibandronate sodium) 150 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ibandronate sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |